KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Cash from Investing Activities readings, the most recent being $95.1 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 826.78% to $95.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$240.3 million, a 286.09% decrease, with the full-year FY2025 number at -$240.3 million, down 286.09% from a year prior.
  • Cash from Investing Activities hit $95.1 million in Q4 2025 for Ginkgo Bioworks Holdings, up from -$72.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $95.1 million in Q4 2025 to a low of -$198.7 million in Q1 2025.
  • Median Cash from Investing Activities over the past 5 years was -$21.2 million (2021), compared with a mean of -$26.2 million.
  • The widest YoY moves for Cash from Investing Activities: up 826.78% in 2025, down 1540.66% in 2025.
  • Ginkgo Bioworks Holdings' Cash from Investing Activities stood at $4.2 million in 2021, then skyrocketed by 603.41% to $29.7 million in 2022, then tumbled by 256.94% to -$46.7 million in 2023, then skyrocketed by 71.97% to -$13.1 million in 2024, then skyrocketed by 826.78% to $95.1 million in 2025.
  • The last three reported values for Cash from Investing Activities were $95.1 million (Q4 2025), -$72.8 million (Q3 2025), and -$63.9 million (Q2 2025) per Business Quant data.